# Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer

> **NCT00004100** · PHASE3 · UNKNOWN · sponsor: **Istituto Nazionale per lo Studio e la Cura dei Tumori**

## Conditions studied

- Lung Cancer

## Interventions

- **DRUG:** cisplatin
- **DRUG:** gemcitabine hydrochloride
- **DRUG:** vinorelbine tartrate

## Key facts

- **NCT ID:** NCT00004100
- **Lead sponsor:** Istituto Nazionale per lo Studio e la Cura dei Tumori
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 1998-11
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2013-12-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00004100

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00004100, "Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00004100. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*